Published in Gene Therapy Weekly, September 21st, 1998
The work is important, researchers say, because it may offer a more effective method of transferring healthy genes into humans with various illnesses such as hemophilia, cystic fibrosis, and sickle cell anemia, and improve treatment.
"We have been able to do this with a piece of DNA five to 20 times the usual size scientists work with," said Dr. Jean...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (1998-09-21)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.